Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Factors Influencing Axillary Lymph Node Metastasis in Invasive Breast Cancer

  • Li, Ling (First Municipal Hospital of Guangzhou affiliated to Guangzhou Medical College) ;
  • Chen, Li-Zhang (School of Public Health, Central South University)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To explore the relationship between auxiliary lymph node metastasis and clinical features, and to identify the factors that affect metastasis occurrence. Methods: A total of 164 cases of primary breast cancer were selected to investigate features such as age, concomitant chronic disease and pathologic diagnosis. Immunohistochemistry was used to detect the expression of the estrogen receptor (ER) and CerbB-2. Logistic regression was employed to analyze the factors that affect the incidence of lymph node metastases. Results: The incidence of lymph node metastases was 46.3% among elderly patients with breast cancer. Based on logistic regression, chronic disease, scale of tumor, age, and ER expression affected the occurrence of lymph node metastases; the ORs were 3.05, 2.18, 0.34, and 3.83, respectively. Between different pathologic diagnoses and the risk factors, the OR scores were 12.7 and 8.02, respectively, for aggressive ductal carcinoma and aggressive lobular carcinoma auxiliary lymph node metastases. Conclusion: The incidence of lymph node metastases is affected by chronic disease, scale of tumor, age, ER expression and pathologic diagnosis.

Keywords

References

  1. Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit (2007). Cancer, 113, 2221- 43. https://doi.org/10.1002/cncr.23844
  2. Azizun-Nisa, Bhurgri Y, Raza F, et al (2008). Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac J Cancer Prev, 9, 553-6.
  3. Bartlett JM, Ellis IO, Dowsett M, et al (2007). Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (er) -negative, but with grade in those with er-positive earlystage breast cancer suitable for cytotoxic chemotherapy. J Clin Oncol, 25, 4423-30. https://doi.org/10.1200/JCO.2007.11.0973
  4. Fisher B, Jeong JH, Anderson S, et al (2002). Twenty-fiveyear follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75. https://doi.org/10.1056/NEJMoa020128
  5. Hooks MA (2010). Breast Cancer: Risk Assessment and Prevention. South Med J, 103, 333-8. https://doi.org/10.1097/SMJ.0b013e3181d39038
  6. Li L, Chen LZ (2010). Clinical characteristics of lymph node metastasis in Elderly breast cancer. J Third Military Medical University, 32, 1503-11.
  7. Li L, Chen LZ (2010). Clinical features, ER, PR and CerbB-2 expressionof elderly breast cancer patients. Chin J Gerontology, 30, 3265-7.
  8. Liu YH (2011). Status of Women with breast cancer disease and risk factors of breast cancer. Modern Prev Med, 38, 468-9.
  9. Louwman WJ, Vulto JC, Verhoeven RH, et al (2007). Clinical epidemiology of breast cancer in the elderly. Eur J Cancer, 43, 2242-52. https://doi.org/10.1016/j.ejca.2007.08.005
  10. Mamounas EP (2009). Age and lymph node status in breast cancer: not a straightforward relationship. J Clin Oncol, 27, 2900-1. https://doi.org/10.1200/JCO.2009.22.0509
  11. Martin M, González Palacios F, Cortes J, et al (2009). Prognostic and predictive factors and genetic analysis of early breast cancer. Clin Transl Oncol, 11, 634-42. https://doi.org/10.1007/s12094-009-0418-7
  12. Pierga JY, Girre V, Laurence V, et al (2004). Characteristics and outcome of 1755 operable breast cancers in women over 70 years of aged. Breast, 13, 369-75. https://doi.org/10.1016/j.breast.2004.04.012
  13. Porter P (2008). "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med, 358, 213-6. https://doi.org/10.1056/NEJMp0708307
  14. Radice D, Redaelli A (2003). Breast Cancer Management Qualityof- Life and Cost Considerations. Pharmacoeconomics, 21, 383-96. https://doi.org/10.2165/00019053-200321060-00003
  15. Voordeckers M, Vinh-Hung V, Van de Steene J, et al (2004). The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol, 70, 225-30. https://doi.org/10.1016/j.radonc.2003.10.015
  16. Wildiers H, Van Calster B, van de Poll-Franse LV, et al (2009). Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol, 27, 2931-7. https://doi.org/10.1200/JCO.2008.16.7619
  17. Yu KD, Li JJ, Di GH, et al (2010). A Straight forward but not piecewise relationship between age and lymph node status in chinese breast cancer patients. PLos One, 5, e11035. https://doi.org/10.1371/journal.pone.0011035
  18. Zhang JQ, Wang S, Xie F (2011). Ten years of chinese breast surgery and prospects. Chin J Breast Disease, 5, 1-6.
  19. Zhang SW, Chen WQ, Kong LZ (2006). Cancer incidence and mortality in Some Chinese cities and counties from (1998) to (2002). Chin Cancer, 15, 430-48.

Cited by

  1. Targeting Tumor Metastasis by Regulating Nm23 Gene Expression vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3539
  2. Comparison of Virtual Touch Tissue Quantification with Strain Ratio in Differentiating Malignant from Benign Cervical Lymph Nodes vol.24, pp.1, 2015, https://doi.org/10.2485/jhtb.24.49